compounded tirzepatide vs mounjaro Public warned illegally sold online Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

Ciclosporin an immunosuppressant where consistent drug levels are critical

The metabolic health startup combines Registered Dietitians with AI-powered care agents to tackle chronic disease and improve long-term outcomes

--- #Pharmacy #EpilepsyAwareness #Neuropharmacology #PharmacistRole #AEDs #HealthEducation To view or add a comment, sign in Market Watch | Bristol Myers Squibbs Cobenfy Faces Uptake Challenges Amid Strong Q3 Earnings Bristol Myers Squibb ($BMY) reported $12.2B in Q3 revenue, surpassing analyst expectations yet investor attention centered on Cobenfy, the first new schizophrenia drug in 35 years, which posted $43M in sales, slightly below forecasts

Although this effect may have a detrimental effect on cardiac outcomes, GLP-1 receptor agonists have been shown to protect cardiac myocytes against ischaemia in animal and human studies